SORMANI, MARIA PIA
 Distribuzione geografica
Continente #
EU - Europa 48.543
AS - Asia 5.296
NA - Nord America 4.407
SA - Sud America 453
AF - Africa 92
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 58.805
Nazione #
IT - Italia 47.690
US - Stati Uniti d'America 4.089
SG - Singapore 2.139
CN - Cina 1.226
VN - Vietnam 710
BD - Bangladesh 687
FR - Francia 413
BR - Brasile 290
HK - Hong Kong 186
DE - Germania 106
CA - Canada 103
MX - Messico 77
FI - Finlandia 70
AR - Argentina 67
IN - India 46
GB - Regno Unito 44
IQ - Iraq 41
JP - Giappone 40
CH - Svizzera 37
JM - Giamaica 35
NL - Olanda 33
ZA - Sudafrica 26
RU - Federazione Russa 25
CR - Costa Rica 23
SA - Arabia Saudita 21
ES - Italia 20
CO - Colombia 19
ID - Indonesia 19
PK - Pakistan 19
TH - Thailandia 19
VE - Venezuela 19
CL - Cile 18
EC - Ecuador 18
GT - Guatemala 17
HN - Honduras 15
TR - Turchia 15
PH - Filippine 13
UA - Ucraina 13
DZ - Algeria 12
KE - Kenya 12
KR - Corea 11
MA - Marocco 11
AU - Australia 10
NP - Nepal 10
TN - Tunisia 10
IE - Irlanda 9
PR - Porto Rico 9
AZ - Azerbaigian 8
JO - Giordania 8
MY - Malesia 8
PE - Perù 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AT - Austria 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
EG - Egitto 6
KZ - Kazakistan 6
PL - Polonia 6
SE - Svezia 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
GR - Grecia 5
PT - Portogallo 5
QA - Qatar 5
RO - Romania 5
RS - Serbia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BB - Barbados 4
BE - Belgio 4
BO - Bolivia 4
IL - Israele 4
IR - Iran 4
KH - Cambogia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
HU - Ungheria 3
KG - Kirghizistan 3
MM - Myanmar 3
OM - Oman 3
PY - Paraguay 3
SC - Seychelles 3
SI - Slovenia 3
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GP - Guadalupe 2
LB - Libano 2
LC - Santa Lucia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
Totale 58.775
Città #
Genova 30.364
Genoa 10.424
Rapallo 3.390
Vado Ligure 2.824
San Jose 1.192
Singapore 974
Ashburn 521
Lauterbourg 387
Ho Chi Minh City 201
Beijing 196
New York 193
Hong Kong 167
Hanoi 153
Santa Clara 117
Bordighera 104
Council Bluffs 100
Los Angeles 79
Frankfurt am Main 70
Helsinki 68
Milan 57
Rome 56
Buffalo 52
Chicago 50
Mexico City 45
Dallas 39
Da Nang 36
Haiphong 35
Tokyo 32
Brooklyn 31
Zurich 31
Tianjin 29
Phoenix 28
São Paulo 28
Naples 27
Toronto 25
Philadelphia 20
Boardman 19
Kingston 19
Florence 18
San José 18
Atlanta 17
Baghdad 16
Bari 16
Louisville 16
San Francisco 16
St Louis 16
Can Tho 15
Guangzhou 15
Guatemala City 15
Hải Dương 15
Bologna 14
Johannesburg 14
Miami 14
Palermo 14
Turin 14
Washington 13
Charlotte 12
Houston 12
Orem 12
Shanghai 12
Amsterdam 11
Cardiff 11
Des Moines 11
Detroit 11
Montreal 11
Nairobi 11
Newark 11
Santiago 11
Bangkok 10
Columbus 10
Denver 10
Jacksonville 10
Nuremberg 10
Schiffdorf 10
Bar Harbor 9
Cincinnati 9
Las Vegas 9
Miano 9
Rio de Janeiro 9
Riyadh 9
San Antonio 9
Amman 8
Baku 8
Boston 8
Cleveland 8
Dublin 8
London 8
Nashville 8
Queens 8
Saint Paul 8
San Diego 8
Austin 7
Baltimore 7
Birmingham 7
Biên Hòa 7
Dhaka 7
Managua 7
New Orleans 7
Ninh Bình 7
Pasadena 7
Totale 52.861
Nome #
High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva. 292
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 247
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 238
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis. 225
Clinical epidemiology of ALS in Liguria, Italy. 219
Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis 214
Evaluation of insulin resistance in a cohort of HIV-infected youth. 211
Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial 211
Different MRI patterns in MS worsening after stopping fingolimod 207
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 206
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 204
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 204
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 200
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 198
Use of maraviroc in clinical practice: a multicenter observational study 198
Modelling the distribution of cortical lesions in multiple sclerosis. 197
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 196
Breast Density Assessment Using a 3T MRI System: Comparison among Different Sequences 196
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. 195
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 195
Indirect comparisons of treatment effects in multiple sclerosis. 193
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 192
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 192
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2) 192
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 192
Can we measure long-term treatment effects in multiple sclerosis? 191
Quantitative assessment of finger motor performance: Normative data 188
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 186
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 186
99mTc-white cell scanning to detect gut inflammation in children with inflammatory bowel diseases or spondyloarthropathies 185
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 185
Defining the clinical course of multiple sclerosis: the 2013 revisions. 184
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial. 183
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 183
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 182
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. 182
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 182
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 182
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 179
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. 178
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. 178
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 178
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis 177
BCR-ABL nuclear entrapment kills human CML cells: ex-vivo study on 35 patients with the combination of Imatynib Mesylate and Leptomycin B 177
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach 177
Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS). 177
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 176
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 175
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. 174
Single-Port Versus Conventional Laparoscopic Cholecystectomy: Better Cosmesis at the Price of an Increased Incisional Hernia Rate? 174
Optimizing therapy early in multiple sclerosis: An evidence-based view 173
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. 172
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. 172
Treatment decisions in multiple sclerosis - insights from real-world observational studies. 172
A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma. 172
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 171
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process 171
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 171
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain 169
Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study 169
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 169
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 168
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment 168
The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis 167
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. 167
Statistical issues related to the use of MRI data in multiple sclerosis 167
Body mass index in Th1 and Th2 diseases. 166
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study. 165
Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis 165
Time to first relapse as an endpoint in multiple sclerosis clinical trials. 165
Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies 164
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 164
The most frequently asked question to a statistician: The sample size 164
Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. 163
Age-related changes in Conventional, Magnetization Transfer, and Diffusion-Tensor MR Imaging Findings: Study with Whole-Brain Tissue Histogram Analysis. 163
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach 163
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 163
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis 163
Approved drugs for multiple sclerosis: The challenge of choice 162
A Comprehensive Review on Copemyl(®) 162
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials 161
Scoring treatment response in patients with relapsing multiple sclerosis. 161
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. 161
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 161
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas 161
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes. 160
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 160
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Establishing disease prognosis and monitoring patients 160
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. 160
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 160
Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging 159
A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis 159
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 159
Quantitative assessment of finger motor impairment in multiple sclerosis. 159
Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis 159
Dosimetric predictors of diarrhea during radiotherapy for prostate cancer. 159
To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy 159
The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis 157
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up 157
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 157
Totale 17.932
Categoria #
all - tutte 200.120
article - articoli 198.982
book - libri 0
conference - conferenze 1.138
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 400.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.124 139 294 581 477 146 361 317 1.214 236 422 299 638
2022/20234.155 462 197 50 416 709 795 19 308 765 58 324 52
2023/20242.426 116 354 57 216 199 513 181 158 145 69 135 283
2024/20256.979 157 607 270 404 944 772 726 953 305 362 620 859
2025/202613.709 1.378 316 855 1.078 1.482 1.358 2.154 621 939 1.370 982 1.176
2026/20271.395 1.395 0 0 0 0 0 0 0 0 0 0 0
Totale 59.915